Accessibility Statement Skip Navigation
  • Resources
  • Blog
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All Public Company News
      • All Multimedia News
      • View All News Releases

      • Regulatory News

      • D/A/CH Regulatory News
      • UK Regulatory News
      • View All Regulatory News

  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Overview
  • Distribution
  • Paid Placement
  • Multichannel Amplification
  • Disclosure Services
  • SocialBoost
  • Rooms
    • MediaRoom
    • ESG Rooms
  • AI Tools
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Hamburger menu
  • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
  • Send a Release
    • Phone

    • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

    • ALL CONTACT INFO
    • Contact Us

      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT

  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • News in Focus
    • Browse News Releases
    • Regulatory News
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • Overview
  • Distribution
  • Paid Placement
  • Multichannel Amplification
  • Disclosure Services
  • Cision Communications Cloud®
  • AI Tools
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists

Prequalified by WHO: SumiShield® 50WG - a new Mode of Action Chemistry for use in the Fight Against Malaria Transmitting Mosquitoes


News provided by

Sumitomo Chemical

27 Oct, 2017, 07:00 GMT

Share this article

Share toX

Share this article

Share toX

LONDON, October 27, 2017 /PRNewswire/ --

  • New active ingredient, Clothianidin, used for the first time in vector control 
  • Single mode of action chemistry for effective rotation strategies 
  • Non-repellent formulation showing excellent biological efficacy for up to nine months against resistant malaria transmitting mosquitoes  

SumiShield 50WG, a new indoor residual spray (IRS) developed by Sumitomo Chemical, is one of the first vector control products to be prequalified by the World Health Organisation (WHO), under the evaluation scheme that would have resulted in a WHOPES recommendation under the previous system. With a brand-new mode of action chemistry for indoor residual spraying (IRS), SumiShield 50WG represents a significant breakthrough, providing a new tool to allow programme managers to rotate between chemistries and be far better equipped to manage resistance.

WHO figures show that nearly half the world's population is at risk of malaria and, despite a drop in both incidence and mortality rates in recent years, there are over 200 million new cases every year. Increased prevention and control measures have led to significant gains, but these are under threat due to insecticide resistance, which affects 75% of countries with ongoing transmission of the disease. Rotating insecticides is one of the key strategies for avoiding resistance, however nearly 87% of affected countries are failing to do this, largely due to a lack of alternative chemistries to choose from.

SumiShield 50WG helps to overcome this challenge, with a single mode of action chemistry based on the neonicotinoid insecticide, clothianidin, giving malaria prevention programmes much greater flexibility when rotating with other chemistries. The formulation has proven efficacy under WHO supervised trials and continues to work effectively for up to nine months after spraying, even against highly resistant mosquitoes.

SumiShield 50WG is a non-repellent formulation resulting in resting mosquitoes being exposed for longer than is the case for many other insecticides, such as pyrethroids, therefore increasing mosquito mortality and product efficacy. The odourless spray has a low mammalian toxicity profile compared with many other IRS products, and also will not stain walls, which creates better acceptance by householders.

Coming in the form of a non-dusty water dispersible granular formulation and packaged in 150g sachets, SumiShield 50WG is simple to use and has light-weight packaging for easy and efficient delivery to villages, even on the back of a bike. The water dispersible granule formulation means it is easily dispensed into the spray tank and dissolves rapidly, making for easy spray operation.  

Dr. Nick Hamon, Chief Executive Officer at Innovative Vector Control Consortium (IVCC), said: "Mosquito resistance to current insecticides is threatening the huge gains made so far in reducing deaths from malaria, so we desperately need effective chemistry with modes of action new to public health to combat these resistant mosquitoes, and enable rotation with other products.  News that SumiShield® 50WG has recently obtained a WHO PQ listing is therefore very welcome indeed.  SumiShield will prove a very valuable tool in the vector control toolbox."

Dr. Mouhamadou Chouaïbou from the Centre Suisse Recherches Scientifiques (Côte d'Ivoire) stated: "The CSRS team has evaluated SumiShield® 50WG and we are really pleased to be able to confirm its excellent and long-lasting residual activity in hut and village scale trials against our highly resistant Tiassale strain mosquitoes. We believe that this product will play an important role in future IRS campaigns - helping to accelerate the elimination and ultimate eradication of malaria."

For further information on the WHO Prequalification of SumiShield, visit: http://www.who.int/pq-vector-control/en/

SumiShield® is a registered trademark of Sumitomo Chemical Company Ltd

About Sumitomo Chemical: 

Founded in 1913, Sumitomo Chemical Company has grown to be one of the world's leading multinational chemical companies with annual sales amounting to US $20.8 billion and 30,000 employees. Today, Sumitomo Chemical includes more than 100 companies operating globally in five business sectors: basic chemicals, petrochemicals & plastics, IT-related chemicals, health & crop sciences and pharmaceuticals. As an expanding global business which pursues leading-edge research and development - over 2,000 employees work in R&D - Sumitomo Chemical continually strives to contribute to the sustainable development of society throughout the world.  In line with this approach, Sumitomo has been manufacturing its life-saving Olyset LLIN in Africa since 2003. In 2008 it opened a purpose-built factory with its joint venture partner A to Z Textiles in Arusha, Tanzania where up to 30 million nets are manufactured per year and at peak 7,000 local people are employed. It has also established an R&D facility at Arusha - the only facility of its size in East and Central Africa to be owned by a private company. For more information about Sumitomo Chemical's Vector Control Department, visit http://www.sumivector.com

For more information, please contact:
Adam Flynn
Email:info@sumivector.com

For media enquiries, please contact:
Jackie Murphy/Sarah Milward
Tel: +44-207-680-7104
Email: jackie.murphy@flagshipconsulting.co.uk sarah.milward@flagshipconsulting.co.uk

Modal title

Contact PR Newswire

  • +44 (0)20 7454 5110
    from 8 AM - 5:30 PM GMT
  • General Enquiries
  • Media Enquiries
  • Partnerships

Products

  • Content Distribution
  • Multimedia Services
  • Disclosure Services
  • Cision Communications Cloud®

About

  • About PR Newswire
  • About Cision
  • Partnering Opportunities
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
  • Data Privacy

Do not sell or share my personal information:

  • Submit via Privacy@cision.com 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
+44 (0)20 7454 5110
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 PR Newswire Europe Limited. All Rights Reserved. A Cision company.